FGFR3 gene mutations in Chinese cases of thanatophoric dysplasia type1

Fetal Diagnosis and Therapy

Volumn 26, Issue 2, 2009, Pages 90-92

  Yang, Yu ^a   Li, Dong Zhi ^b  

^a Department of Obstetrics and Gynecology ^*  (China)

^b GUANGZHOU MATERNAL AND NEONATAL HOSPITAL   (China)

Author keywords

FGFR3 gene; Molecular diagnosis; Thanatophoric dysplasia type 1

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; DNA SEQUENCE; FETUS; FETUS ECHOGRAPHY; GENE MUTATION; HETEROZYGOSITY; HUMAN; PRIORITY JOURNAL; THANATOPHORIC DWARFISM;

AMINO ACID SUBSTITUTION; FEMALE; HUMANS; PREGNANCY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SEQUENCE ANALYSIS, DNA; THANATOPHORIC DYSPLASIA; ULTRASONOGRAPHY, PRENATAL;

EID: 70350751559     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000238120     Document Type: Article

References (10)

1. Miller E, Blaser S, Shannon P, Widjaja E: Brain and bone abnormalities of thanatophoric dwarfism. Am J Roentgenol 2009; 192: 48-51.
2. Vajo Z, Francomano CA, Wilkin DJ: The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000; 21: 23-39.
3. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ: Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995; 9: 321-328.
4. Krakow D, Alanay Y, Rimoin LP, Lin V, Wilcox WR, Lachman RS, et al: Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis. Am J Med Genet A 2008; 146A:1917-1924.
5. Rimoin DL, Cohn DH, Eyre D: Clinical-molecular correlations in the skeletal dysplasias. Pediatr Radiol 1994; 24: 425-426.
6. Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS, Alanay Y: The skeletal dysplasias: clinical-molecular correlations. Ann N Y Acad Sci 2007; 1117: 302-309.
7. Tsutsumi S, Sawai H, Nishimura G, Hayasaka K, Kurachi H: Prenatal diagnosis of thanatophoric dysplasia by 3-D helical computed tomography and genetic analysis. Fetal Diagn Ther 2008; 24: 420-424.
8. Wong HS, Kidd A, Zuccollo J, Tuohy J, Strand L, Tait J, Pringle KC: A case of thanatopho ric dysplasia: the early prenatal 2D and 3D sonographic findings and molecular confirmation of diagnosis. Fetal Diagn Ther 2008; 24: 71-73.
9. Camera G, Baldi M, Strisciuglio G, Concolino D, Mastroiacovo P, Baffico M: Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype. Am J Med Genet 2001; 104: 277-281.
10. Pokharel RK, Alimsardjono H, Takeshima Y, Nakamura H, Naritomi K, Hirose S, Onishi S, Matsuo M: Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene. Biochem Biophys Res Commun 1996; 227: 236-239.